Expertise

Early and Late Clinical Stage Commercial Strategy

Oncology Solid Tumors

  • Platinum Resistant Ovarian Cancer

  • Clear Cell Renal Cell Carcinoma

  • Pancreatic Adenocarcinoma

  • Non-Small Cell Lung Cancer

  • Head & Neck Squamous Cell Carcinoma

  • Metastatic Colorectal Cancer

Oncology Liquid Tumors

  • Non-Hodgkin’s Lymphoma

  • Follicular Lymphoma

  • Diffuse Large B-Cell Lymphoma

  • Acute Myeloid Lymphoma

  • Proximal Nocturnal Hemoglobinuria (PNH)

  • Multiple Myeloma

Other Disease Areas

  • Epidermolysis Bullosa

  • CNS Major Depression Disorder/Anxiety, Eating Disorders

  • Endometriosis and Uterine Fibroids

  • Anaphylaxis/Envenomation

  • Moderate to Severe Asthma

  • Neovascular Age - Related Macular Degeneration

  • Plaque Psoriasis

  • Status Epilepticus

Product Launches

Company’s First Product Launch

  • Platinum Resistant Ovarian Cancer

  • DLBCL – Antibody Drug Conjugate

  • Pediatric Low-Grade Glioma (pLGG)

  • Osteoporosis – First Biologic

  • Non-Muscle Invasive Bladder Cancer

  • Hypercholesterolemia – Small Molecule, Combination Therapy

  • Primary IgA Nephropathy - First in the Disease Area

Other Significant Launches

  • Epidermolysis Bullosa – Indication Expansion

  • CNS Migraine – Global Launch Strategy Including Ground-Breaking Advocacy Program

  • Osteoporosis & Bone Metastasis

  • Melanoma – First and Only Oncolytic Virus US and Global Launch

  • Paroxysmal Nocturnal Hemoglobinuria – Global Launch

  • Rheumatoid Arthritis - Relaunch

Post Launch LCM, Market Expansion, Competitive Entry Strategy

  • Cancer Treatment Supportive Care – Novel Drug Delivery System

  • Rheumatoid Arthritis – Disease Area Expansion to Psoriatic Arthritis, Ankylosing

  • Psoriasis - Launch Preparation

  • Wound Management – OTC Ointment, Development of 510k & ODD Pathway

  • Multiple Myeloma – Global Lifecycle Management and Strategy

  • Hyperuricemia – Patient Support Services

  • Cataplexy and Excessive Sleepiness in Narcolepsy – Patient Support Services

  • Breast Cancer – Market Expansion